BioCentury This Week

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.

For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Ep. 292 - Myasthenia Gravis Spotlight & AACR Preview
Apr 25, 2025 – 25:51
Ep. 291 - Grand Rounds - U.S. Preview
Apr 24, 2025 – 31:02
Ep. 290 - Biotech Survey Sees Tough Days Ahead. Plus: FDA, China Speed
Apr 21, 2025 – 38:10
Ep. 289 - Replacing Animal Models. Plus: RFK Jr. & FDA
Apr 14, 2025 – 36:55
Ep. 288 - FDA and Tariffs Turmoil, and AACR Preview
Apr 7, 2025 – 26:34
Ep. 287 - The Bear is Back: Marks’ Ouster, Tariffs and a Tumbling XBI
Mar 31, 2025 – 25:46
Ep. 286 - Sofinnova’s Pan-European Accelerator, China Biotechs, Trump Tariffs
Mar 24, 2025 – 24:30
Ep. 285 - BIO's Trump 2.0 Plan. Plus: Autoimmune CAR Ts & Telix's Radiopharma Play
Mar 17, 2025 – 28:26
Ep. 284 - Takeaways from the East-West Summit
Mar 11, 2025 – 41:27
Ep. 283 - Makary’s FDA Agenda, Amylin in Obesity and Life After DEI
Mar 10, 2025 – 31:30
Ep. 282 - CRISPR Lessons: Plus, AbbVie Enters Obesity
Mar 3, 2025 – 23:46
Ep. 281 - Roche Reboot and 5 Things on Trump 2.0
Feb 24, 2025 – 22:12
Ep. 280 - China Competition. Plus: FDA Firings and Biotech IPOs
Feb 18, 2025 – 27:52
Ep. 279 - East-West Summit Preview
Feb 14, 2025 – 29:54
Ep. 278 - Trump 2.0’s Impact on FDA, NIH. Plus: Precision Medicine
Feb 10, 2025 – 26:14
Ep. 277 - Asia's NewCo Model, FDA Tipping Point, Vertex's Pain Drug
Feb 3, 2025 – 25:03
Ep. 276 - Precision Neuropsychiatry Spotlight With ICON's Peter Schueler
Jan 31, 2025 – 21:07
Ep. 275 - Series As & Innovation. Plus: Rocky Transition at FDA, NIH
Jan 27, 2025 – 33:09
Ep. 274 - 2025 Biotech Preview: Markets, Catalysts and AI
Jan 21, 2025 – 36:21
Ep. 273 - JPM 2025 Wrap: Sunny Skies & Megarounds
Jan 16, 2025 – 22:21
Ep. 272 - JPM Deal Buzz & Rep. Auchincloss’ Take on Biopharma
Jan 13, 2025 – 27:29
Ep. 271 - Biotech in the New Year. Plus: Beyond Biosecure
Jan 6, 2025 – 34:54
Ep. 270 - Temple’s FDA Legacy. Plus: Chinese Innovation & Novo Obesity Data
Dec 30, 2024 – 34:56
Bonus Content - Trends in Global Biopharma Deals: Lazard’s Kingston and Raine
Dec 23, 2024 – 34:54
Ep. 269 - Trends in VC Funds, Obesity Start-ups and More
Dec 16, 2024 – 33:14
Ep. 268 - Biosecure Setback & Novartis' $1B PTC Deal
Dec 9, 2024 – 21:49
Ep. 267 - Trump's NIH Pick & Multi-targeted CAR Ts
Dec 2, 2024 – 27:26
Ep. 266 - Jefferies Recap, FDA Commissioner & Biosecure Update
Nov 25, 2024 – 26:32
Ep. 265 - RFK Jr. & HHS, Blenrep's Comeback, China Deals
Nov 18, 2024 – 29:42
Ep. 264 - Prepping for Trump & Alzheimer's Ethics
Nov 11, 2024 – 29:10
Ep. 263 - Alzheimer Insights: Anti-Amyloid Safety & Tau Teaser
Nov 4, 2024 – 34:38
Ep. 262 - EGFR Case Study, FDA & Politics
Oct 28, 2024 – 23:38
Ep. 261 - China Summit: Reinventing Your China Strategy
Oct 23, 2024 – 31:39
Ep. 260 - VC Funds, New Chapter for MS, Wave's Data
Oct 21, 2024 – 31:18
Ep. 259 - Causal Biology and Big Data, Ultra-Rare Drugs at FDA
Oct 14, 2024 – 33:50
Ep. 258 - Breaking the Bear: 4Q Public Markets Preview
Oct 7, 2024 – 39:44
Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
Sep 30, 2024 – 32:19
Ep. 256 - ESMO Recap: Keeping TIGIT Alive, Rybrevant & Immunotherapy Anniversary
Sep 25, 2024 – 26:57
Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss
Sep 23, 2024 – 21:49
Ep. 254 - Takeaways from Grand Rounds 2024
Sep 20, 2024 – 34:39
Ep. 253 - IPOs, GLP-1 & Obesity, AI & Biotech
Sep 16, 2024 – 32:58
Ep. 252 - Akeso's Bispecific, Vaxcyte & Woodcock's Quality Mindset
Sep 9, 2024 – 18:37
Ep. 251 - Eyes on the target: a Back to School Overview
Sep 6, 2024 – 31:38
Ep. 250 - Biosecure, Priority Review Vouchers & Target Discovery
Sep 4, 2024 – 30:07
Ep. 249 - Biotech IPO Buzz, Pharma Deal Trends, Washington Update
Aug 26, 2024 – 29:22
Ep. 248 - Grand Rounds Preview: Eyes on the Target
Aug 22, 2024 – 33:36
Ep. 247 - Drug Pricing, Psychedelic Setback & Back to School
Aug 19, 2024 – 25:57
Ep. 246 - Wilson’s Vision for Gene Therapy. Plus: Korea Biotech & Grand Rounds
Aug 12, 2024 – 32:21
Ep. 245 - Biotech-Academia Deals, Leqembi's Latest, Wilson Moves On
Aug 5, 2024 – 25:35
Ep. 244 - Leqembi's Thumbs-Down in Europe. Plus: Perioperative Cancer, Pediatric Review Vouchers
Jul 29, 2024 – 29:41

Recent Reviews

Ios9 problem

terrific summaries capturing the news in this fast-moving space

LOVE this weekly look at what is happening in biotech, both deep dives into the science itself plus the regulatory/legislative challenges and more. All the regulars are deeply knowledgeable and Jeff Cranmer’s levity as host makes the pod enjoyable and digestible--you really do feel like you have a seat at their editorial meetings. GREAT recaps of the news and in ~30 min or less, I look forward to listening each week!
Surfrider182

Great insights and wisdom!

Awesome helps me and my team navigate efficiently
Pretty Kitty 2

Simone Fishburn!!!!

Simone Fishburn is so well spoken and such a tremendous host. Need more of her in our lives !!